«Zalcitabine

Below is an extended Zalcitabine patents listing. Click here to return to the Zalcitabine main in depth entry.

Patents :
US Patent No.	Title
7390787	Compositions and methods for treating infections using analogues of indolicidin
7411051	Antibodies to HDPPA04 polypeptide
7417040	Fused tricyclic compounds as inhibitors of 17.beta.-hydroxysteroid dehydrogenase 3
7417121	Human G-protein coupled receptor, HGPRBMY39
7419811	Use of specifically engineered enzymes to enhance the efficacy of prodrugs
7419963	Indole antiviral compositions and methods
7419969	HIV integrase inhibitors: cyclic pyrimidinone compounds
7427600	Active agent delivery systems and methods for protecting and administering active agents
7429646	Antibodies to human tumor necrosis factor receptor-like 2
7429656	Inhibition of SARS-associated coronavirus (SCoV) infection and replication by RNA interference
7429660	ATM inhibitors
7405292	Cellular genes regulated by HIV-1 infection and methods of use thereof
7405234	Bicyclic modulators of androgen receptor function
7402600	Nitroderivatives of cardiovascular agents
7393533	H3L envelope protein immunization methods and H3L envelope passive protection methods
7393534	Compositions and methods for immunotherapy of cancer and infectious diseases
7393634	Screening for disease susceptibility by genotyping the CCR5 and CCR2 genes
7393662	Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
7393855	2,2-bis-(hydroxymethyl)cyclopropylidenemethyl-purines and pyrimidines as antiviral agents
7393934	Human G-protein chemokine receptor (CCR5) HDGNR10
7396830	Piperazine amidines as antiviral agents
7396840	Chemokine receptor binding heterocyclic compounds
7399763	8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as HIV integrase inhibitors
7399878	Pharmaceutical compounds
7432304	Small molecule antagonists of Bcl-2 family proteins
7432374	Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
7449575	Substituted diamino-1,3,5-triazine derivatives
7452538	Death domain containing receptor 4 antibodies and methods
7452550	Liposomal antineoplastic drugs and uses thereof
7452867	Use of ADNF polypeptides for treating peripheral neurotoxicity
7452901	Anti-cancer phosphonate analogs
7452992	Heterocyclic compounds as CCR5 antagonists
7455833	Methods and compositions for treating viral infections using antibodies and immunoconjugates to aminophospholipids
7456155	2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
7456220	Immunodulatory compositions and methods of use thereof
7456251	HIV fusion inhibitor peptides with improved biological properties
7449493	Diamines as modulators of chemokine receptor activity
7449476	Tetrahydrocarboline antiviral agents
7449467	3-aminocyclopentanecarboxamides as modulators of chemokine receptors
7435728	Pyrazole derivatives
7435734	N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
7435735	Hydroxy pyridopyrrolopyrazine dione compounds useful as HIV integrase inhibitors
7435737	Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
7435808	Polynucleotides encoding novel adiponectin receptor variant, AdipoR2v2
7438203	Dermal penetration enhancers and drug delivery systems involving same
7438929	Multi-particulate form of medicament, comprising at least two differently coated forms of pellet
7442375	Compositions of beta-defensin inducing agents
7442703	Piperidine derivatives useful as CCR5 antagonists
7446176	12 human secreted proteins
7456256	BGS 4

All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.